GlassScriptPhysician profile
Kenneth M Cahill
NPI 1053336792
$1,466.87
in general payments reported to CMS, 2019-2025
24 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $34.40 · 2021: $200 · 2022: $268 · 2023: $282 · 2024: $191 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $385.05 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $165.86 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Bayer Healthcare Pharmaceuticals INC. | $149.40 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $108.89 | 2023-2025 | Myfembree |
| Pfizer INC. | $99.52 | 2021-2024 | |
| Hologic Sales and Service, LLC | $79.77 | 2021-2024 | Fluent Fluid Management System, Myosure Tissue Removal Device, Acessa Provu System |
| Daiichi Sankyo INC. | $63.14 | 2021-2024 | Injectafer |
| Exact Sciences Corporation | $51.12 | 2023-2025 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $39.90 | 2021-2022 | |
| Organon LLC | $36.83 | 2024-2025 | Nexplanon |
| Evofem Biosciences, INC. | $32.94 | 2024-2025 | Solosec, Phexx, Phexxi |
| Millicent US INC | $32.77 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Amag Pharmaceuticals, INC. | $30.50 | 2019 | |
| Allergan, INC. | $27.99 | 2019 | |
| Coopersurgical, INC. | $25.04 | 2019-2023 | Advincula Delineator Uterine Manipulator |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.32 | 2024 | Pico 7 |
| Medtronic, INC. | $17.11 | 2022 | |
| Roche Diagnostics Corporation | $17.02 | 2019 | |
| Therapeuticsmd, INC. | $14.78 | 2019 | |
| Minerva Surgical, INC | $14.63 | 2019 | |
| Amgen INC. | $14.61 | 2021 | |
| Myovant Sciences INC. | $14.45 | 2022 | |
| Mayne Pharma Commercial LLC | $14.37 | 2022 | |
| Radius Health, INC. | $12.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Cahill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.